BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 26082369)

  • 1. [Application of Mimics three-dimensional imaging in percutaneous left atrial appendage closure with Watchman system].
    Yang D; Xu Z; Zhang Y; Luo Y; Zhang J; Wang Y; Gunalingam B; Zhang X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Apr; 43(4):352-7. PubMed ID: 26082369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.
    Chen YY; Zhang YH; Chen X; Huang WP; Xu B; Su X; Chen YH
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1831-1839. PubMed ID: 31321654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.
    Calvo N; Salterain N; Arguedas H; Macias A; Esteban A; García de Yébenes M; Gavira JJ; Barba J; García-Bolao I
    Europace; 2015 Oct; 17(10):1533-40. PubMed ID: 25935163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of real-time three-dimensional transesophageal echocardiography in peri-operation of transcatheter left atrial appendage closure.
    Zhou Q; Song H; Zhang L; Deng Q; Chen J; Hu B; Wang Y; Guo R
    Medicine (Baltimore); 2017 Jan; 96(4):e5637. PubMed ID: 28121919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous closure of the left atrial appendage: a new option for the prevention of thromboembolic stroke].
    Oto A; Aytemir K; Okutucu S; Kaya EB; Sahiner L; Sabanov C; Evranos B
    Turk Kardiyol Dern Ars; 2011 Dec; 39(8):668-74. PubMed ID: 22257805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.
    Massumi A; Chelu MG; Nazeri A; May SA; Afshar-Kharaghan H; Saeed M; Razavi M; Rasekh A
    Am J Cardiol; 2013 Mar; 111(6):869-73. PubMed ID: 23312129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D printing for sizing left atrial appendage closure device: head-to-head comparison with computed tomography and transoesophageal echocardiography.
    Hell MM; Achenbach S; Yoo IS; Franke J; Blachutzik F; Roether J; Graf V; Raaz-Schrauder D; Marwan M; Schlundt C
    EuroIntervention; 2017 Nov; 13(10):1234-1241. PubMed ID: 28671551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism - First Results From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Ootomo T; Takayama M; Ando K; Hirao K; Morino Y; Hayashida K; Kusano K; Main ML; Saito S
    Circ J; 2018 Nov; 82(12):2946-2953. PubMed ID: 30305484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation.
    Stone D; Byrne T; Pershad A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):121-7. PubMed ID: 23765504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
    Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
    J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Foley D; Sievert H; Mazzone P; De Potter T; Vireca E; Stein K; Bergmann MW;
    Heart Rhythm; 2017 Sep; 14(9):1302-1308. PubMed ID: 28577840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices.
    Heeger CH; Rillig A; Lin T; Mathew S; Deiss S; Lemes C; Botros M; Metzner A; Wissner E; Kuck KH; Ouyang F; Tilz RR
    Heart Rhythm; 2015 Jul; 12(7):1524-31. PubMed ID: 25769512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.